| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $20.78B | +43.6% |
| Cost of Revenue | $11.20B | +54.1% |
| Gross Profit | $9.58B | +32.9% |
| R&D Expense | $1.93B | +5.6% |
| SG&A Expense | $963.0M | +25.7% |
| Operating Income | $2.63B | +44.3% |
| Pre-tax Income | $2.43B | +56.6% |
| Income Tax | $521.0M | -8.4% |
| Net Income | $1.91B |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.63B | +3.1% |
| Short-term Investments | $4.49B | +28.9% |
| Accounts Receivable | $255.0M | +63.5% |
| Inventory | $296.0M | +24.4% |
| Current Assets | $20.14B | +40.9% |
| Total Assets | $25.20B | +42.8% |
| Current Liabilities | $16.60B | +47.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $7.92B | +54.0% |
| Investing Cash Flow | -$8.29B | -140.2% |
| Financing Cash Flow | $1.96B | +833.7% |
| +93.6% |
| EPS (Basic) | $37.69 | +91.9% |
| EPS (Diluted) | $37.69 | +93.7% |
| Long-term Debt |
| $5.71B |
| +27.1% |
| Total Liabilities | $20.84B | +43.0% |
| Stockholders' Equity | $4.35B | +41.7% |